CINECA IRIS Institutional Research Information System

NENCETTI, SUSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.514
EU - Europa 6.902
AS - Asia 6.148
SA - Sud America 814
AF - Africa 202
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 27.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.861
CA - Canada 2.566
FI - Finlandia 2.071
SG - Singapore 1.917
CN - Cina 1.791
IT - Italia 1.550
HK - Hong Kong 850
SE - Svezia 799
BR - Brasile 689
DE - Germania 557
VN - Vietnam 401
BG - Bulgaria 356
PL - Polonia 354
GB - Regno Unito 319
FR - Francia 312
TR - Turchia 279
KR - Corea 220
IN - India 182
JP - Giappone 172
RU - Federazione Russa 165
UA - Ucraina 151
BD - Bangladesh 69
SN - Senegal 47
CH - Svizzera 46
IQ - Iraq 45
AR - Argentina 42
ES - Italia 38
MX - Messico 37
AT - Austria 34
NL - Olanda 34
ID - Indonesia 31
BE - Belgio 30
CI - Costa d'Avorio 30
ZA - Sudafrica 29
PK - Pakistan 23
NG - Nigeria 21
VE - Venezuela 20
SA - Arabia Saudita 18
EC - Ecuador 17
MA - Marocco 16
KE - Kenya 13
PE - Perù 13
GR - Grecia 12
CZ - Repubblica Ceca 11
MY - Malesia 11
TH - Thailandia 11
TW - Taiwan 11
AU - Australia 10
EG - Egitto 10
IE - Irlanda 10
PH - Filippine 10
UZ - Uzbekistan 10
CO - Colombia 9
DK - Danimarca 9
IL - Israele 9
JO - Giordania 9
TN - Tunisia 9
IR - Iran 8
JM - Giamaica 8
KZ - Kazakistan 8
LT - Lituania 8
NP - Nepal 8
OM - Oman 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
PY - Paraguay 7
AZ - Azerbaigian 6
BO - Bolivia 6
BY - Bielorussia 6
DZ - Algeria 6
ET - Etiopia 6
PA - Panama 6
UY - Uruguay 6
CL - Cile 5
CR - Costa Rica 5
HR - Croazia 5
NZ - Nuova Zelanda 5
RO - Romania 5
AL - Albania 4
AO - Angola 4
BB - Barbados 4
HU - Ungheria 4
KG - Kirghizistan 4
SY - Repubblica araba siriana 4
BJ - Benin 3
HN - Honduras 3
PT - Portogallo 3
RS - Serbia 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
Totale 27.574
Salva come PNG Salva come JPEG
Città #
Montreal 2.307
Helsinki 1.912
Singapore 1.118
Ashburn 1.112
Woodbridge 1.045
Hong Kong 842
Ann Arbor 827
Santa Clara 719
Chandler 656
Houston 644
San Jose 612
Fairfield 600
Dallas 498
Shanghai 369
Sofia 354
Serra 350
Beijing 323
Hefei 299
Milan 284
New York 279
Seattle 269
Wilmington 224
Seoul 204
Cambridge 199
Ottawa 194
Izmir 185
Jacksonville 185
Princeton 179
Boardman 178
Los Angeles 145
Tokyo 143
Lawrence 136
Medford 130
Lauterbourg 125
Council Bluffs 121
Des Moines 113
Nanjing 109
Ho Chi Minh City 105
Florence 97
London 96
Dearborn 80
Dong Ket 68
Istanbul 67
Buffalo 63
Frankfurt am Main 63
Munich 58
Pisa 58
Redondo Beach 54
Hanoi 53
São Paulo 53
Rome 52
Redwood City 51
Bremen 47
Dakar 47
Bern 45
Columbus 42
Marseille 38
Ogden 37
Lancaster 36
The Dalles 36
San Diego 35
Orem 33
Nanchang 31
Abidjan 30
Jüchen 30
Vienna 30
Pune 29
Brussels 28
Livorno 28
Rio de Janeiro 28
Chicago 27
Boulder 26
Bures-sur-Yvette 26
Kunming 25
Chennai 24
Warsaw 24
Baghdad 23
Shenyang 23
Turku 23
Belo Horizonte 22
San Francisco 22
Brooklyn 21
Fuzhou 21
Paris 21
Pessac 21
Jiaxing 20
Toronto 20
Atlanta 19
Lagos 19
Brasília 18
Changsha 18
Jakarta 18
Nürnberg 18
Lucca 17
Norwalk 17
Trieste 17
Auburn Hills 16
Dhaka 16
Hebei 16
Phoenix 16
Totale 20.251
Salva come PNG Salva come JPEG
Nome #
Synthesis and a- and ß-adrenergic activity of spiromorpholines structurally related to sympathomimetic catecholamines 4.645
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs 364
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 253
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 238
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 235
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 232
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 224
SYNTHESIS AND EVALUATION OF THE PHARMACOLOGICAL ACTIVITY OF RIGID ANALOGUES OF SYMPATHOMIMETIC DERIVED FROM BICYCLO[2.2.1]HEPTANE 222
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies 222
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 220
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 214
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators 211
Inhibition of [125] ET-1 binding to ETA receptors by salicilic acid dimers 208
Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles 208
Synthesis and antimicrobial properties of new cepham and penam derivatives with the carboxylic group in the "wrong" ß-configuration 207
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter 206
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 206
Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: synthesis and antiinflammatory properties 201
CONFORMATIONALLY RESTRAINED ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES - SYNTHESIS AND ADRENERGIC ACTIVITY OF TETRAHYDROBENZOCYCLOHEPTENE DERIVATIVES 200
Sintesi e proprietà farmacologiche di analoghi semirigidi morfolinici e piperidinici di catecolamine simpatomimetiche. Modelli sterici per l'attivazione diretta dei recettori a- e ß-adrenergici. 196
3-(METHYLENEAMINOXY)METHYLPIPERIDINE DERIVATIVES AS UPTAKE INHIBITORS OF BIOGENIC-AMINES IN THE BRAIN SYNAPTOSOMAL FRACTION 196
Resveratrol-like Compounds as SIRT1 Activators 195
Copper mediated amyloid-β binding to Transthyretin 195
Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds 195
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 192
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 192
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 191
Age-related macular degeneration: Current knowledge of zinc metalloproteinases involvement 191
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors 190
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization 188
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 188
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 188
MOLECULAR DESIGN, SYNTHESIS, AND ANTIINFLAMMATORY ACTIVITY OF A SERIES OF BETA-AMINOXYPROPIONIC ACIDS 187
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 187
SYNTHESIS AND EVALUATION OF THE PHARMACOLOGICAL ACTIVITY OF RIGID ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES DERIVED FROM BICYCLO[2.2.1]HEPTANE 185
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 183
Synthesis and 5-HT2A, 5-HT1Aand a1-Binding Affinities of 2-[2- Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-Hydroxy-3-(2- pyridin-2-yl-ethyl)amino]- and 2-[2-Hydroxy-3-(4-N-methylpiperazin- 1-yl)-amino]propoxybenzaldehyde-O-(substituted) Benzyl Oximes 182
Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models 182
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 182
7-Nitrobenzofurazan (NBD)-Derivatives Of 5'-N-Ethylcarboxamidoadenosine (NECA) As New Fluorescent Probes For Human A3 Adenosine Receptors 180
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 179
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 178
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 178
3-(Methyleneaminoxy)methylpiperidine derivatives as uptake inhibitors of biogenic amines in the brain synaptosomal fraction 177
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 177
Synthetic analogs of xanthohumol for use in the prevention and​/or treatment of tumors 177
Exploring the binding of quercetin-3-O-metabolites with transthyretin 177
Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-a Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models 176
4-ARYLPIPERIDINE DERIVATIVES AND USE THEREOF FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CNS DISEASE 175
1-(1-pirril)-3- ammino-2-propanoli N-sostituiti: sintesi e proprietà ß-adrenergiche 173
Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines 173
Synthesis and β-adrenergic properties of tetrahydronaphthalene analogs of dichloroisoproterenol 170
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 169
Sintesi e proprietà beta-adrenergiche di [(benzilideneammino)ossi] propanolammine orto-ossipropanolammine sostituite chirali, 165
Compounds with a benzo [a]carbazole structure for use in the prevention and/or treatment of infectious diseases 164
TTR fibril formation inhibitors: is there a SAR? 164
Role of the benzylic hydroxyl group of adrenergic catecholamines in eliciting a-adrenergic activity. Synthesis and a1- and a2-adrenergic activity of 3-phenyl-3-piperidinols and of their desoxy analogs 164
Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives 164
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 163
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors 162
WILSON & GISVOLD CHIMICA FARMACEUTICA (Capitolo 15) 158
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 156
Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis 155
Powerful twin carboxylic inhibitors for MMP homodimerization 155
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease 153
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP 153
Allosteric inhibition of ET-1 binding to ETA receptors by aldoxime derivatives 152
A new crystal form of human transthyretin obtained with a curcumin derived ligand 152
Synthesis and affinity for serotonin and dopamine transporters of some benzophenone oxime ether derivatives 151
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 151
Comparison of helical scan and standard rotation methods in single-crystal X-ray data collection strategies 151
Sintesi e attività recettoriale adrenergica di analoghi tetraidronaftalenici di catecolamine simpatomimetiche 150
Synthesis and aldose reductase inhibitory activity of some N-(aroyl)-N-(arylalkyloxy)-glycines and -beta-alanines 149
X-ray crystal structure and activity of fluorenyl-based compounds as transthyretin fibrillogenesis inhibitors 149
Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease 148
CONFORMATIONAL EFFECTS ON THE ACTIVITY OF DRUGS .13. A REVISION OF PREVIOUSLY PROPOSED MODELS FOR THE ACTIVATION OF ALPHA-ADRENERGIC AND BETA-ADRENERGIC RECEPTORS 148
Synthesis and aldose reductase inhibitory activity of N-(aroyl)- and N-(arylsulfonyl)-N-(benzyloxy)aminoacetic acids. 148
Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress 147
Effetti conformazionali sull'attività dei farmaci. Sintesi e proprietà farmacologiche di cis-2-aril-3-metilmorfoline 147
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR) 147
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 146
Effetti conformazionali sull'attività dei farmaci. Sintesi e valutazione dell'attività farmacologica di analoghi rigidi di catecolamine simpatomimetiche derivati dal norbornano 145
Conformational effects on the activity of drugs. Synthesis and a and ß-adrenergic receptor activity of new terahydronaphthalene analogs of sympathomimetic catecholamines 145
Sintesi ed attività adrenergica di analoghi ciclici dell’1-(2,5-dimetossifenil)-2-amminoetanolo 145
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of a- and ß-adrenergic receptors 143
NMR STUDIES OF A NEW POTENT MMP-12 INHIBITOR: INSIGHT INTO KEY BINDING INTERACTIONS 143
Synthesis and aldose reductase inhibitory activity of new N-(benzyloxy) glycine derivatives 143
Uncommon formation of spiro orthoesters in the bromomethoxylation reaction of a 4-[(aroyloxy)methyl]-3-cephem derivative 143
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates 143
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 142
A new small molecule, D2 dopamine receptor agonist, as an allosteric modulator of A2A adenosine receptor signalling 139
Transthyretin complexes with curcumin and bromo-estradiol: Evaluation of solubilizing multicomponent mixtures 139
Natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (MMP-2) and MMP-9 in alzheimer’s disease 139
Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications 138
Conformationally restrained analogs of sympathomimetic catecholamine. Synthesis and adrenergic activity of tetrahydrobenzocycloheptene derivatives 138
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 138
Higher Crystallization Success Obtained for TTR-ligand Complexes Using a New Approach 137
SYNTHESIS AND BETA-ADRENERGIC ACTIVITY OF A SERIES OF 3-(SUBSTITUTED-BENZYLIDENEAMINOXY)PROPANOLAMINE DERIVATIVES 136
Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents 135
Sintesi ed attività α- e ß-adrenergica di analoghi benzocicloeptanici di catecolamine simpatomimetiche 132
Totale 21.935
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 0 0 160
2021/20221.831 45 193 39 98 315 219 66 94 71 49 115 527
2022/20232.223 290 299 167 217 224 284 26 143 364 12 147 50
2023/20244.115 202 134 157 81 235 280 84 53 27 2.639 79 144
2024/20255.018 18 181 124 273 525 473 497 295 468 576 602 986
2025/20267.507 445 821 654 498 502 460 871 253 2.197 493 233 80
Totale 28.009